CN101780222B - 一种治疗癫痫病的中药组合物及其制备方法 - Google Patents
一种治疗癫痫病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN101780222B CN101780222B CN2010101313414A CN201010131341A CN101780222B CN 101780222 B CN101780222 B CN 101780222B CN 2010101313414 A CN2010101313414 A CN 2010101313414A CN 201010131341 A CN201010131341 A CN 201010131341A CN 101780222 B CN101780222 B CN 101780222B
- Authority
- CN
- China
- Prior art keywords
- percent
- rhizoma gastrodiae
- chinese medicine
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 206010015037 epilepsy Diseases 0.000 title abstract description 22
- 239000011021 lapis lazuli Substances 0.000 claims abstract description 33
- 241000208340 Araliaceae Species 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 235000008434 ginseng Nutrition 0.000 claims abstract description 22
- 241000489492 Arisaema Species 0.000 claims abstract description 20
- 210000000941 bile Anatomy 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000006837 decompression Effects 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 10
- 241000644519 Chloritis Species 0.000 claims description 30
- 230000001037 epileptic effect Effects 0.000 claims description 22
- 241000522620 Scorpio Species 0.000 claims description 19
- 239000009490 scorpio Substances 0.000 claims description 19
- 241000237636 Pheretima Species 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 7
- 239000011812 mixed powder Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 13
- 238000011161 development Methods 0.000 abstract description 2
- 229910001919 chlorite Inorganic materials 0.000 abstract 3
- 229910052619 chlorite group Inorganic materials 0.000 abstract 3
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 abstract 3
- 238000002156 mixing Methods 0.000 abstract 3
- 241000361919 Metaphire sieboldi Species 0.000 abstract 2
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 2
- 241000239226 Scorpiones Species 0.000 abstract 2
- 241001530126 Scrophularia Species 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 description 21
- 230000036461 convulsion Effects 0.000 description 21
- 229940079593 drug Drugs 0.000 description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 208000026435 phlegm Diseases 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 11
- 239000003172 expectorant agent Substances 0.000 description 10
- 230000003419 expectorant effect Effects 0.000 description 10
- 208000005392 Spasm Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010019468 Hemiplegia Diseases 0.000 description 4
- 206010039897 Sedation Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000036280 sedation Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000024658 Epilepsy syndrome Diseases 0.000 description 3
- 208000002877 Epileptic Syndromes Diseases 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000003925 brain function Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001709 ictal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 208000010540 rapid respiration Diseases 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000243684 Lumbricus Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗癫痫病的中药组合物,按质量百分比由胆南星18%-25%,天麻12%-18%,青礞石8%-12%,地龙10%-18%,黄芩15%-22%,人参5%-12%,玄参5%-12%,全蝎3%-5%组成,含量总和为100%。先将青礞石加水煎煮3小时,将青礞石药渣与天麻质量的1/3、以及黄芩、玄参、地龙混合,加水煎煮,然后过滤出煎液,总共加水煎煮3次,每次1.5小时;将三次滤出的煎液合并,减压浓缩成稠膏状混合物,然后取称得的天麻质量的2/3与胆南星、人参、全蝎混合粉碎成细粉状并与稠膏状混合物混合,减压,干燥,即得。本发明的治疗癫痫病的中药组合物,疗效好,见效快,有效降低病人对于癫痫病的发病频率。
Description
技术领域
本发明属于中药技术领域,涉及一种治疗癫痫病的中药组合物,本发明还涉及该中药组合物的制备方法。
背景技术
癫痫在祖国医学中,称为“痫证”,癫痫病俗称“羊羔风”,是一种突发性,短暂性大脑功能失调性疾病。发病率较高,可发生于任何年龄,青少年尤为多见。原发性癫痫也叫特发性癫痫、无器质性病变并具有遗传倾向。它是一组特定的癫痫综合症,对于儿童往往和年龄有密切关系,有些与遗传因素有关系。癫痫是由多种原因引起的慢性脑功能障碍临床综合征,是大脑神经细胞群反复超同步放电所引起的发作性、突然性、反复性、短暂性脑神经系统功能紊乱。癫痫具有发作性、复发性和自然缓解性的特点,是一种慢性、反复发作性的脑功能失常性疾患。目前癫痫病有许多治疗手段,但各种治法只能缓解病人暂时的症状,而不能从根本上治疗。
发明内容
本发明的目的是提供一种治疗癫痫病的中药组合物,可以根治癫痫病,且见效快、不复发。
本发明的另一目的是提供上述治疗癫痫病中药组合物的制备方法。
本发明所采用的技术方案是,一种治疗癫痫病的中药组合物,按质量百分比由以下原料的有效成分组成:胆南星18%-25%,天麻12%-18%,青礞石8%-12%,地龙10%-18%,黄芩15%-22%,人参5%-12%,玄参5%-12%,全蝎3%-5%,以上组分的含量总和为100%。
本发明所采用的另一技术方案是,治疗癫痫病的中药组合物的制备方法,按以下步骤进行:
步骤1.
按照质量百分比,分别称取18%-25%的胆南星,12%-18%的天麻,8%-12%的青礞石,10%-18%的地龙,15%-22%的黄芩,5%-12%的人参,5%-12%的玄参,3%-5%的全蝎,以上组分的含量总和为100%;
步骤2.
将步骤1称得的青礞石加适量水煎3个小时,过滤出青礞石药渣,取步骤1称得的天麻质量的1/3,将青礞石药渣与天麻质量的1/3、以及步骤1称得的黄芩、地龙、玄参混合,加水煎煮,然后过滤出煎液,总共加水煎煮3次,每次1.5小时;将三次滤出的煎液合并,减压浓缩成稠膏状混合物,减压过程中温度为50℃-60℃,真空度为0.06Mpa-0.07Mpa,然后取步骤1称得的天麻质量的2/3与步骤1称得的胆南星、人参、全蝎混合粉碎成细粉状并与稠膏状混合物混合,减压,温度为60℃-70℃,真空度为0.07Mpa-0.08Mpa,干燥,即得。
本发明的治疗癫痫病的中药组合物,疗效好,见效快,采用治调结合的手段,在癫痫的治疗上取得了非常好的效果。能够有效降低病人对于癫痫病的发病频率,从而提高病人的生活质量。
具体实施方式
下面结合具体实施例对本发明进行详细说明。
本发明的治疗癫痫病的中药组合物,按质量百分比由以下原料的有效成分组成:
胆南星18%-25%,天麻12%-18%,青礞石8%-12%,地龙10%-18%,黄芩15%-22%,人参5%-12%,玄参5%-12%,全蝎3%-5%,以上组分的含量总和为100%。
本发明的治疗癫痫病的中药组合物的制备方法,具体按照以下步骤实施:
步骤1.
按照质量百分比,分别称取18%-25%的胆南星,12%-18%的天麻,8%-12%的青礞石,10%-18%的地龙,15%-22%的黄芩,5%-12%的人参,5%-12%的玄参,3%-5%的全蝎,以上组分的含量总和为100%;
步骤2.
将步骤1称得的青礞石加适量水煎3个小时,过滤出青礞石药渣,取步骤1称得的天麻质量的1/3,将青礞石药渣与天麻质量的1/3、以及步骤1称得的黄芩、地龙、玄参混合,加水煎煮,然后过滤出煎液,总共加水煎煮3次,每次1.5小时;将三次滤出的煎液合并,减压浓缩成稠膏状混合物,减压过程中温度为50℃-60℃,真空度为0.06Mpa-0.07Mpa,然后取步骤1称得的天麻质量的2/3与步骤1称得的胆南星、人参、全蝎混合粉碎成细粉状并与稠膏状混合物混合,减压,温度为60℃-70℃,真空度为0.07Mpa-0.08Mpa,干燥,即得。
本发明的治疗癫痫病的中药组合物,可以加适量辅料压制成片剂、填成胶囊、制成丸剂或加其他赋形剂制成其他制剂。
用法及用量:
口服,每次服用1.2克,一天3次,10天一疗程,每服用10日,间隔一个星期再服用。
各原料在本药物中的功能及功能主治:
胆南星,味苦、微辛,凉。归肺、肝、脾经。具有清热化痰,息风定惊。能开结痰,豁浊气以还清。用于痰热咳嗽,咯痰黄稠,中风痰迷,癫狂惊痫。在方中为君药。
天麻,味甘、辛、平,无毒。归肝、脾、肾、胆、心、膀胱经。具有息风止痉;平肝潜阳;祛风通络的作用。主急慢惊风;抽搐拘挛;眩晕;头痛;半身不遂;肢麻;风湿痹痛。能入营透表泻风,脑髓之病,从积气以化。李时珍在《本草纲目》中对历代书籍中关于天麻功效的论述作了总结归纳:天麻“辛,温,无毒。久服益气力,长阴,肥健,轻身,增年。消臃肿,下肢满,寒疝下血。主治风湿,四肢拘挛,瘫痪不遂;小儿风痛,惊气,助阳气,补五壤七伤;风虚眩晕头痛,通血脉,开窍。服食无忌等”。现代药理研究表明:天麻具有镇痛作用;镇静作用;抗惊厥作用;明目、增智作用。在方中为臣药。
青礞石,味甘、咸,平。归肺、心、肝经。坠痰下气,平肝镇惊。用于顽痰胶结,咳逆喘急,癫痫发狂,烦躁胸闷,惊风抽搐。其体重而降,能消一切积聚痰结,消积滞,坠痰涎,诚为要药。然其攻击太过,性复沉坠,凡积滞症结脾胃壮实者可用,如虚弱者忌之;小儿惊痰食积实热,初发者可用,虚寒久病者忌之。在方中为臣药。
地龙,原名蚯蚓。性味咸、寒,入肝、脾、肺、膀胱经,有清热息风、清肺平喘、通经活络、清热利尿之功,适用于壮热惊厥、抽搐、肺热咳喘、风湿热痹、关节红肿疼痛、曲伸不利、热结膀胱、小便不利等。本品性寒体滑,下行降泄,善能清热平肝,息风止痉。《本草纲目》言其“其性寒而下行,性寒故有解诸热疾,下行故能利小便,治足疾而通经络也”。药理研究表明,本品含蚯蚓解热碱、蚯蚓素、蚯蚓毒素等,有解热镇静、抗惊厥、扩张支气管作用。在方中为臣药。
黄芩,味苦,寒。归肺、胆、脾、大肠、小肠经。可清热燥湿,泻火解毒,止血,安胎。用于湿温、暑温胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。黄芩清肝胆之郁热,使半里之邪得从内彻。在方中为佐药。
人参,性平,味甘、微苦。大补元气、固脱生津、安神之药。主治劳伤虚损、食少、倦怠、反胃吐食、大便滑泄、虚咳喘促、自汗暴脱、惊悸、健忘、眩晕头痛、阳痿、尿频、消渴、妇女崩漏、小儿慢惊及久虚不复,一切气血津液不足之证。癫痫病属于高热风痰实证,久病正气严重亏损,人参能补久虚,滋肺金以融木。在方中为佐药。
玄参,味甘、苦、咸;性微寒。归肺,胃,肾经。具有清热凉血,泻火解毒,滋阴之功。主治温邪入营,内陷心包,温毒发斑,热病伤阴、舌绛烦渴、津伤便秘、骨蒸劳嗽、目赤、咽痛、瘰疬、白喉、痈肿疮毒。.《本草正》:玄参,此物味苦而甘,苦能清火,甘能滋阴,以其味甘,故降性亦缓。《本草》言其惟入肾经,而不知其尤走肺脏,故能退无根浮游之火,散周身痰结热痈。在方中为佐药。
全蝎,辛,平;有毒。归肝经。具有息风镇痉,攻毒散结,通络止痛之作用。用于小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,偏正头痛。现代药理研究表明:具有抗惊厥和抗癫痫作用,对脑神经的修复作用。全蝎在解除癫痫之抽搐痉挛;中风口歪;半身不遂;头痛之表征有不同凡响之功。在方中为佐药。
癫痫病是一种突发性,短暂性大脑功能失调性疾病。痫证为患,不外乎风、痰、火、瘀、虚、病之初起和发作之时,邪气有余,多为风、痰、火、瘀标证,当以治标为要。本方组成,贵在豁痰定痫,熄风止痉,清热除烦,行气止痛。方中胆南星为君药,具有清热化痰,熄风定惊。用于痰热咳嗽,咯痰黄稠,中风痰迷,癫狂惊痫。天麻、青礞石和地龙为臣药。天麻具有平肝熄风,祛风止痛之功,本品甘平,润而不燥,主入肝经,长于平肝息风,凡肝风内动、头目眩晕之症,不论虚实,均为要药。青礞石:坠痰下气,平肝镇惊。用于顽痰胶结,咳逆喘急,癫痫发狂,烦躁胸闷,惊风抽搐。增强君药的化痰定惊之效。方中的地龙具有清热熄风,清热平喘,通经活络的作用。用于壮热惊厥、抽搐、肺热咳喘、风湿热痹等。加强了君药胆南星清热熄风通络以定惊。方中的黄芩、人参、玄参、全蝎为佐药。黄芩:清热燥湿,泻火解毒。痰浊蒙蔽心窍,痰多湿盛,而黄芩清热燥湿效果明显。人参为大补元气、固脱生津、安神之药,癫痫病属于慢性病,反复发作性病,宜长期用药,病久易伤正气,故选用人参补正气,并其有安神的功效,利于癫痫病的康复。玄参清热凉血,泻火解毒,滋阴。肝风内动,易于伤阴,故取玄参滋阴之功,以解阴虚之症。全蝎在解除癫痫之抽搐痉挛;中风口;半身不遂;头痛之表征有不同凡响之功。方中7味药互配可相得益彰,在治疗由痰浊蒙蔽心窍,肝风内动引起的原发性癫痫病有非常好的疗效。
药效学实验:
1.镇痛、镇静作用:
本方制剂用水稀释给小白鼠灌胃,能明显降低小白鼠对热疼痛及化学刺激引起的疼痛反应,且小白鼠的活动度明显降低。表明其有明显的镇痛作用,且持续时间长,且有一定的镇静作用。
2.抗惊厥作用:
本方制剂用水稀释给小白鼠灌胃,能对小白鼠有镇静作用。对小白鼠的电惊厥也能对抗,对五甲烯四氮唑及咖啡因引起的惊厥有拮抗作用。
3.解热作用:
药理实验表明:本方制剂对于因大肠杆菌毒素引起的发热家兔具有良好的解热作用,其退热作用温和。
4.扩张气管、平喘作用:
有良好的平喘解痉作用。本方制剂对药物性哮喘有明显的保护作用;能明显降低组胺或乙酰胆碱对气管和回肠平滑肌痉挛收缩的反应性。
毒性实验:
对小白鼠口服的最大耐受量是35g生药/kg/日,为成人临床用量的200倍。长期毒性试验中,在给本方制剂药液9g生药/kg/日的高剂量下,连用30日后对大白鼠均未产生任何毒副反应,也未观察到药物对大白鼠重要脏器及肝肾功能的明显影响,因此认为本法制剂毒性很低,所推荐的临床用药剂量是安全的。
病例一
咸阳市渭城区,解某,30岁。患癫痫病15余年。服用本药1年,每服用10日,间隔1月,其发病由原来每月一次,变为3个月、5个月一次。发病次数明显减少。病人发病症状减轻。
病例二
杨凌镇杨某,女,年龄45岁,患癫痫病8余年,采用中、西药治疗很多年,一直未见好转。服用本药8个月,至今还未见发病。
病例三
安康市,张某,男,19岁。3年前正在上体育课,突然倒地,双目上视,咬牙,口吐涎沫,两手握拳,肢体抽搐,面色煞白,老师迅速用手掐其人中,约2~3分钟后醒来,只觉头晕乏力,其他不知。此后每年发作2-3次,经安康市中医院检查,诊断为癫痫。服用本药半年后,至今未见癫痫复发。
实施例1
按照质量百分比,分别称取18%的胆南星,12%的天麻,8%的青礞石,11%的地龙,22%的黄芩,12%的人参,12%的玄参,5%的全蝎,将称得的青礞石加适量水煎3个小时,过滤出青礞石药渣,取称得的天麻质量的1/3,将青礞石药渣与天麻质量的1/3、以及称得的黄芩、玄参、地龙混合,加水煎煮,然后过滤出煎液,总共加水煎煮3次,每次1.5小时;将三次滤出的煎液合并,减压浓缩成稠膏状混合物,减压过程中温度为50℃,真空度为0.06Mpa,然后取称得的天麻质量的2/3与称得的胆南星、人参、全蝎混合粉碎成细粉状并与稠膏状混合物混合,减压,温度为60℃,真空度为0.07Mpa,干燥,即得。
实施例2
按照质量百分比,分别称取25%的胆南星,18%的天麻,11%的青礞石,18%的地龙,15%的黄芩,5%的人参,5%的玄参,3%的全蝎,将称得的青礞石加适量水煎3个小时,过滤出青礞石药渣,取称得的天麻质量的1/3,将青礞石药渣与天麻质量的1/3、以及称得的黄芩、玄参、地龙混合,加水煎煮,然后过滤出煎液,总共加水煎煮3次,每次1.5小时;将三次滤出的煎液合并,减压浓缩成稠膏状混合物,减压过程中温度为60℃,真空度为0.07Mpa,然后取称得的天麻质量的2/3与称得的胆南星、人参、全蝎混合粉碎成细粉状并与稠膏状混合物混合,减压,温度为70℃,真空度为0.08Mpa,干燥,即得。
实施例3
按照质量百分比,分别称取23%的胆南星,16%的天麻,12%的青礞石,10%的地龙,18%的黄芩,9%的人参,8%的玄参,4%的全蝎,将称得的青礞石加适量水煎3个小时,过滤出青礞石药渣,取称得的天麻质量的1/3,将青礞石药渣与天麻质量的1/3、以及称得的黄芩、玄参、地龙混合,加水煎煮,然后过滤出煎液,总共加水煎煮3次,每次1.5小时;将三次滤出的煎液合并,减压浓缩成稠膏状混合物,减压过程中温度为55℃,真空度为0.065Mpa,然后取称得的天麻质量的2/3与称得的胆南星、人参、全蝎混合粉碎成细粉状并与稠膏状混合物混合,减压,温度为65℃,真空度为0.075Mpa,干燥,即得。
Claims (2)
1.一种治疗癫痫病的中药组合物,其特征在于,按质量百分比由以下原料的有效成分组成:
胆南星18%-25%,天麻12%-18%,青礞石8%-12%,地龙10%-18%,黄芩15%-22%,人参5%-12%,玄参5%-12%,全蝎3%-5%,以上组分的含量总和为100%。
2.一种治疗癫痫病的中药组合物的制备方法,其特征在于,按照以下步骤实施:
步骤1.
按照质量百分比,分别称取18%-25%的胆南星,12%-18%的天麻,8%-12%的青礞石,10%-18%的地龙,15%-22%的黄芩,5%-12%的人参,5%-12%的玄参,3%-5%的全蝎,以上组分的含量总和为100%;
步骤2.
将步骤1称得的青礞石加适量水煎3个小时,过滤出青礞石药渣,取步骤1称得的天麻质量的1/3,将青礞石药渣与天麻质量的1/3、以及步骤1称得的黄芩、玄参、地龙混合,加水煎煮,然后过滤出煎液,总共加水煎煮3次,每次1.5小时;将三次滤出的煎液合并,减压浓缩成稠膏状混合物,减压过程中温度为50℃-60℃,真空度为0.06Mpa-0.07Mpa;然后取步骤1称得的天麻质量的2/3与步骤1称得的胆南星、人参、全蝎混合粉碎成细粉状并与稠膏状混合物混合,减压,温度为60℃-70℃,真空度为0.07Mpa-0.08Mpa,干燥,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101313414A CN101780222B (zh) | 2010-03-23 | 2010-03-23 | 一种治疗癫痫病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101313414A CN101780222B (zh) | 2010-03-23 | 2010-03-23 | 一种治疗癫痫病的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101780222A CN101780222A (zh) | 2010-07-21 |
CN101780222B true CN101780222B (zh) | 2011-10-26 |
Family
ID=42520446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101313414A Active CN101780222B (zh) | 2010-03-23 | 2010-03-23 | 一种治疗癫痫病的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101780222B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105749026B (zh) * | 2016-05-12 | 2020-05-08 | 刘宏伟 | 一种治疗癫痫病的中药制剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1045535C (zh) * | 1992-11-23 | 1999-10-13 | 高永汉 | 息风定痫丸的制作方法 |
CN1051237C (zh) * | 1994-06-30 | 2000-04-12 | 许新升 | 治疗癫痫病的药物 |
-
2010
- 2010-03-23 CN CN2010101313414A patent/CN101780222B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101780222A (zh) | 2010-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102895603B (zh) | 一种用于治疗肠胃病的中草药 | |
CN104383363B (zh) | 治疗痛风的中药组合物 | |
CN103071023B (zh) | 一种有效治疗消渴症的中药组合物 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN103705809B (zh) | 一种治疗痛风的中药 | |
CN104027462B (zh) | 一种治疗骨关节炎的中药制剂及其制备方法 | |
CN101912506A (zh) | 一种治疗慢性结肠炎的中药制剂 | |
CN103877438A (zh) | 治疗痛风的中药制剂及其生产方法 | |
CN106266999A (zh) | 一种治疗心神不安及心悸失眠的中药组合物及其制备方法 | |
CN101780222B (zh) | 一种治疗癫痫病的中药组合物及其制备方法 | |
CN105709074A (zh) | 一种治疗风湿性关节炎及骨质增生的药物及制备方法 | |
CN104548025A (zh) | 一种治疗痛经的中药丸及其制备方法 | |
CN104800771A (zh) | 一种用于儿童夜惊症的中药制剂及其制备方法 | |
CN102935214B (zh) | 一种治疗尿毒症的中药组合物 | |
CN104056172A (zh) | 一种治疗胃病的中药组合物及其胶囊的制备方法 | |
CN102772536A (zh) | 治疗肝炎并发肝硬化腹水的中药方剂 | |
CN107854633A (zh) | 治疗痛风的组合物及其制备方法 | |
CN101485718B (zh) | 治疗风湿骨病的药物及其制备方法 | |
CN106344811A (zh) | 一种治疗风湿病的中药制剂及制备方法 | |
CN102836343B (zh) | 一种用于结肠护理和治疗结肠炎的药物 | |
CN106361881A (zh) | 一种用于治疗阴囊湿疹的汤剂药物及其制备方法 | |
CN105456499A (zh) | 一种用于治疗便秘的中药制剂及制备方法 | |
CN104623387A (zh) | 一种用于治疗慢性肾炎的药物组合物 | |
CN104840827A (zh) | 一种治疗胃肠功能紊乱的健胃片剂及制法 | |
CN104586944A (zh) | 一种治疗传染性肝炎的中药组合物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 710300 No. 18 Caotang 4th Road, Caotang Science and Technology Industrial Base, Xi'an High-tech Zone, Shaanxi Province Patentee after: Shaanxi Hantang Pharmaceutical Co., Ltd. Address before: 710018 No. 39 Mingguang Road, Xi'an Economic Development Zone, Shaanxi Province Patentee before: Shaanxi Province Academy of Traditional Chinese Medicine Hantang Pharmaceutical Co., Ltd. |